O

OctreoPharm Sciences GmbH

7 employees

OctreoPharm Sciences is focused on the development of new radio pharmaceuticals for neuroendocrine tumors.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

2009

Funding rounds raised

Total raised

$7.2M

from 2 investors over 2 rounds

O

OctreoPharm Sciences GmbH raised $7.2M on April 12, 2011

Investors: IBB Beteiligungsgesellschaft mbH and KfW

FAQ